IRF4 and lymphoid neoplasm: In almost all cases, IRF4/MUM1 is expressed in RS cells, presumably due to NF-κB pathway activation; however, it has little significance in terms of diagnosis, since other lymphoid neoplasms mimicking CHLs also frequently express MUM1 [51].